Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Grants Priority Review for Cabozantinib in Medullary Thyroid Cancer
FDA Grants Priority Review for Cabozantinib in Medullary Thyroid Cancer
FDA Grants Priority Review for Cabozantinib in Medullary Thyroid Cancer
Submitted by
admin
on July 30, 2012 - 11:00am
Source:
Yahoo
News Tags:
FDA
cabozantinib
medullary thyroid cancer
Exelixis
Headline:
FDA Grants Priority Review for Cabozantinib in Medullary Thyroid Cancer
Do Not Allow Advertisers to Use My Personal information
